News
The Food and Drug Administration approved a new, highly effective HIV-prevention medication. The drug nearly eliminated HIV’s ...
The twice-yearly injectable drug’s potential could be compromised by the Trump administration’s dramatic cuts to ...
WASHINGTON (AP) — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, maker Gilead Sciences announced ...
The U.S. Food and Drug Administration on Wednesday approved Gilead Sciences lenacapavir, a twice-yearly injection, for ...
The drug could change the course of the AIDS epidemic. But the Trump administration has gutted the programs that might have paid for it in low-income countries.
A newly posted agenda for next week’s meeting of the just-appointed group of outside vaccine advisers to the US Centers for ...
The launch of the injection faces potential threats, including the Trump administration's proposed cuts to federal funding ...
A new twice-yearly shot could be a "game changer" in the fight against AIDS, but experts' hopes have dimmed because of the ...
The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...
Texas Will Invest $50 Million in Ibogaine Research, Testing the Psychedelic Drug’s Medical Potential
The state's new law marks one of the largest government investments into psychedelics to date, with advocates citing the drug ...
A federal judge in Texas has upheld the U.S. Food and Drug Administration's decision to remove Novo Nordisk's blockbuster ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results